EWSR1 is a multifunctional RNA-binding protein that serves as both a transcriptional regulator and a structural component of cellular homeostasis. The protein binds to ssRNA containing the consensus sequence 5'-AGGUAA-3' and functions as a transcriptional repressor under normal conditions 1. Beyond transcriptional roles, EWSR1 maintains centromere identity by interacting with CENP-A through its prion-like SYGQ2 domain and RNA-recognition motif, binding centromeric R-loops to preserve centromeric chr22 architecture 2. EWSR1 also functions as a checkpoint regulator in immune responses, with the TRAF3-EWSR1 signaling axis negatively regulating germinal center formation and IgG production by suppressing Bcl6 upregulation 3. Disease relevance centers on EWSR1 fusion proteins, which are the most common rearrangements in mesenchymal neoplasias 4. The EWSR1-FLI1 fusion, present in 85% of Ewing sarcoma cases, creates a tumor-specific chimeric transcription factor with neomorphic effects that massively rewires the transcriptome and reprograms the epigenome by inducing de novo enhancers at GGAA microsatellites 5. Emerging therapeutic approaches target factors that promote EWSR1-FLI1 expression, such as C1GALT1, with FDA-approved itraconazole showing promise in reducing tumor growth 6. EWSR1 rearrangements also associate with angiomatoid fibrous histiocytoma and other sarcoma subtypes.